Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Change in Accured Expenses (2010 - 2026)

Geron (GERN) posted Change in Accured Expenses of -$21.0 million for Q1 2026, down 232.1% sequentially from $15.9 million in Q4 2025, and down 59.11% YoY from -$51.4 million in Q1 2025.

Geron (GERN) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Geron has reported Change in Accured Expenses for 17 years, with the latest figure at -$21.0 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 59.11% year-over-year to -$21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (up 196.91% YoY) and the FY2025 annual result came in at $15.8 million, up 431.79% from the prior year.
  • Change in Accured Expenses slipped to -$21.0 million in Q1 2026 per GERN's latest filing, from $15.9 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $28.0 million in Q3 2022 and troughed at -$21.0 million in Q1 2026.
  • A 5-year average of $29176.5 and a median of -$3.9 million in 2023 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses jumped 1980.45% in 2022, then slumped 1340.64% in 2023.
  • Over 5 years, Change in Accured Expenses stood at -$20.6 million in 2022, then surged by 81.2% to -$3.9 million in 2023, then sank by 142.67% to -$9.4 million in 2024, then surged by 269.08% to $15.9 million in 2025, then sank by 232.1% to -$21.0 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$21.0 million, $15.9 million, and $21.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Geron 1.02 Mn -299.83 Mn - -382,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -382,000.00
Jun 30, 2026 -382,000.00
Mar 31, 2026 -21.01 Mn
Mar 31, 2026 -21.01 Mn
Dec 31, 2025 15.90 Mn
Dec 31, 2025 15.90 Mn
Sep 30, 2025 21.37 Mn
Sep 30, 2025 21.37 Mn
Jun 30, 2025 -8.28 Mn
Jun 30, 2025 -8.28 Mn
Mar 31, 2025 -13.20 Mn
Mar 31, 2025 -13.20 Mn
Dec 31, 2024 -9.41 Mn
Dec 31, 2024 -9.41 Mn
Sep 30, 2024 9.56 Mn
Sep 30, 2024 9.56 Mn
Jun 30, 2024 4.81 Mn
Jun 30, 2024 4.81 Mn
Mar 31, 2024 -9.72 Mn
Mar 31, 2024 -9.72 Mn